Name | Number of supported studies | Average coverage | |
---|---|---|---|
endothelial cell | 10 studies | 23% ± 8% | |
oligodendrocyte | 10 studies | 39% ± 17% | |
endothelial cell of lymphatic vessel | 5 studies | 28% ± 6% | |
rod bipolar cell | 3 studies | 18% ± 2% |
Name | Number of supported studies | Average coverage | |
---|---|---|---|
brain | 6 studies | 26% ± 13% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
brain | 100% | 9346.31 | 2640 / 2642 | 99% | 41.62 | 697 / 705 |
ovary | 100% | 3765.86 | 180 / 180 | 97% | 42.35 | 419 / 430 |
esophagus | 100% | 8536.89 | 1445 / 1445 | 97% | 72.26 | 177 / 183 |
uterus | 100% | 6037.12 | 170 / 170 | 92% | 59.40 | 424 / 459 |
lung | 100% | 6057.62 | 576 / 578 | 90% | 30.46 | 1034 / 1155 |
adrenal gland | 100% | 2908.10 | 257 / 258 | 88% | 16.86 | 203 / 230 |
bladder | 100% | 7374.86 | 21 / 21 | 86% | 73.33 | 432 / 504 |
thymus | 91% | 2182.20 | 592 / 653 | 92% | 25.38 | 556 / 605 |
skin | 100% | 11131.53 | 1809 / 1809 | 80% | 19.64 | 376 / 472 |
breast | 100% | 4258.10 | 459 / 459 | 71% | 10.72 | 792 / 1118 |
prostate | 99% | 4925.88 | 243 / 245 | 59% | 8.56 | 296 / 502 |
kidney | 91% | 2345.54 | 81 / 89 | 61% | 11.59 | 552 / 901 |
intestine | 83% | 3754.06 | 803 / 966 | 59% | 12.40 | 313 / 527 |
stomach | 54% | 2290.76 | 194 / 359 | 73% | 14.97 | 208 / 286 |
spleen | 100% | 7556.83 | 241 / 241 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 100% | 49.36 | 1 / 1 |
blood vessel | 100% | 6760.00 | 1334 / 1335 | 0% | 0 | 0 / 0 |
adipose | 100% | 5122.65 | 1200 / 1204 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 98% | 66.10 | 44 / 45 |
heart | 97% | 4161.13 | 839 / 861 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 96% | 20.31 | 77 / 80 |
pancreas | 2% | 34.47 | 7 / 328 | 87% | 30.86 | 154 / 178 |
muscle | 53% | 1002.45 | 428 / 803 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 21% | 1.82 | 6 / 29 |
liver | 2% | 45.30 | 5 / 226 | 14% | 2.01 | 58 / 406 |
peripheral blood | 1% | 13.24 | 8 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0007165 | Biological process | signal transduction |
GO_0051056 | Biological process | regulation of small GTPase mediated signal transduction |
GO_0070062 | Cellular component | extracellular exosome |
GO_0005829 | Cellular component | cytosol |
GO_0005096 | Molecular function | GTPase activator activity |
Gene name | ARHGAP23 |
Protein name | Rho GTPase-activating protein 23 ARHGAP23 Rho GTPase activating protein 23 Rho GTPase-activating protein 23 (Rho-type GTPase-activating protein 23) |
Synonyms | KIAA1501 |
Description | FUNCTION: GTPase activator for the Rho-type GTPases by converting them to an inactive GDP-bound state. . |
Accessions | A0A087WZ73 A0A2X0SFL7 A0A087X1W6 A0A9L9PXS4 ENST00000616767.2 ENST00000620417.4 [Q9P227-2] ENST00000620329.1 A0A9L9PXQ2 ENST00000631490.1 ENST00000614693.1 A0A087WZZ2 ENST00000634129.1 ENST00000616909.1 ENST00000610551.2 [Q9P227-1] ENST00000618942.1 A0A087WXU2 ENST00000620325.1 ENST00000633302.1 A0A087WTU4 ENST00000633443.1 A0A087X0Z0 ENST00000631799.1 [Q9P227-2] ENST00000622683.5 [Q9P227-1] ENST00000633445.2 ENST00000632895.1 ENST00000632947.1 Q9P227 ENST00000619156.1 |